Kin Health has raised $9 million in seed funding to build something the AI-scribe boom skipped: a medical notetaker that belongs to the patient, not the doctor. The round was led by Maveron, with Town Hall Ventures, Pear VC, Eniac Ventures, and more than 30 physician investors — plus GoodRx co-founders Doug Hirsch and Trevor Bezdek.
What it does
The app works like a meeting notetaker pointed at a doctor's office. A patient records the visit; Kin transcribes it, converts the transcript into a clinical narrative, then compresses that into a plain-language summary with action items. The result can be shared with family. The company — built by physicians Arpan and Amit Parikh with Kyle Alwyn, who previously sold the online-prescription service HeyDoctor to GoodRx — says the app encrypts patient data, keeps summaries private by default, and adheres to HIPAA-grade privacy standards even though, as a patient-facing tool, it is not HIPAA-certified.
Why the patient side is the interesting side
AI medical scribes are not new — Abridge, Microsoft's Nuance, and a dozen others have spent two years selling ambient documentation to hospitals, all of it built to cut the physician's charting burden. Kin inverts the customer. The record of what was said in the exam room has always belonged to the provider; the patient walks out with a fading memory and a printout. Handing the patient their own structured, searchable version of the visit is a small change in tooling and a real change in who controls the narrative of their care.
The model worth watching
Kin says the app will be free forever and will monetize through referrals — routing users to specialists and labs. That is a clean consumer pitch and a structural thing to keep an eye on: a free health app whose revenue depends on sending you somewhere has an incentive baked into its summaries' "next steps." It is the same tension that follows AI's broader move into healthcare — the technology is genuinely useful, and the business model around it is where the scrutiny belongs. For now, $9 million and a physician-heavy cap table say the people closest to the exam room think the patient-owned record is worth building.
Comments